Akihiro Kawauchi: Influence Statistics

Akihiro Kawauchi

Akihiro Kawauchi

Shiga University of Medical Science: Shiga Ika Daigaku | Department of Urology, Shiga University of Medical Science, Shiga, Japan. | Department of Urology, Shiga University of ...

Akihiro Kawauchi: Expert Impact

Concepts for which Akihiro Kawauchi has direct influence: Prostate cancer , Germ cell , Bladder capacity , Bladder cancer , Nocturnal enuresis , Renal cell carcinoma , Cyclin d1b .

Akihiro Kawauchi: KOL impact

Concepts related to the work of other authors for which for which Akihiro Kawauchi has influence: Nocturnal enuresis , Prostate cancer , Erectile dysfunction , Renal cell carcinoma , Apoptosis protein , Urinary tract , Overactive bladder .

KOL Resume for Akihiro Kawauchi

Year
2022

Shiga University of Medical Science: Shiga Ika Daigaku

2021

Department of Urology, Shiga University of Medical Science, Setatsukinowa-cho, Otsu, Shiga 520-2192, Japan

2020

Department of Urology, Shiga University of Medical Science, Otsu, Japan

2019

Department of Urology, Shiga University of Medical Science, Tsukinowa-cho, Seta, Otsu, Shiga, 520-2192, Japan.

2018

Department of Urology, Shiga University of Medical Science, Seta Tsukinowa-cho, 520-2192, Otsu, Shiga, Japan

2017

Division of Urology, Shiga University of Medical Science, Setatsukinowa-cho, Otsu, Shiga 520-2192, Japan

2016

Department of Urology, Shiga University of Medical Science Hospital, Seta Tsukinowa-cho, Otsu City, Shiga, Japan

2015

Depatrment of Urology, Shiga University of Medical Science, Otsu, Japan, .

Shiga University of Medical Science Department of Urology

2014

Department of Urology, Shiga University of Medical Science, Otsu, Japan, .

2013

Kyoto Prefectural University of Medicine Department of Urology Graduate School of Medical Science Kyoto Japan

2012

Department of Urology, Graduate School of Medical Science Kyoto Prefectural University of Medicine, Kyoto, Japan

2011

Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto

2010

Department of Molecular Cell Physiology, Department of Urology, Department of Respiratory Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, These authors equally contributed to the present work

Kyoto, Japan

2009

Department of Urology, Kyoto Prefectural University of Medicine, Uji, Kyoto, Japan

2008

Department of Urology, Kyoto Prefectural University of Medicine, Kawaramachi Hirokoji, 602-8566, Kyoto, Japan

2007

Department of Urology, Kyoto Prefectural University, Kyoto 602-8319, Japan

2006

Department of Urology, Kyoto Prefectural University of Medicine and

Kyoto Prefectural University of Medicine, Kyoto, Japan; Osaka University, Osaka, Japan

2005

Departments of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan, 
*Omihachiman City Hospital, Shiga, Japan, 
†Nantan General Hospital, Kyoto, Japan, and 
¶Nagoya Urology Hospital, Nagoya, Japan

2004

Sweden New Zealand Australia/Hong Kong Italy Italy Germany S. Korea USA Japan Sweden France New Zealand Denmark USA Belgium Hong Kong on Behalf of the International Children’s Continence Society (ICCS)

From the Section of Laparoscopic and Minimally Invasive Surgery, Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, Ohio and the Department of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan

Department of Microbiology, Immunology, and Molecular Genetics, Jonsson Comprehensive Cancer Center, UCLA School of Medicine, University of California at Los Angeles, Los Angeles, CA

2003

Department of Urology, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kyoto, Japan

2002

Departments of Urology, Kyoto Prefectural University of Medicine, Kyoto, and

2001

Department of Urology, Kyoto Prefectural University of Medicine, Kamigyo‐ku, Kyoto 602‐8566, Japan

2000

From the Department of Urology, Kyoto Prefectural University of Medicine, Kyoto and Department of Physiology, Fukushima Medical University School of Medicine, Fukushima, Japan

Department of Urology,Research Institute for Neurological Diseases and Geriatrics,Kyoto Prefectural University of Medicine,Kawaramachi Hirokoji,Kamigyo-ku,Kyoto 602-8566

1998

Department of Urology, Kyoto Prefectural University of Medicine, Japan

1996

Department of Urology, Kyoto Prefectural University of Medicine, Japan.

1993

Department of Urology, Kyoto Prefectural University of Medicine.

Prominent publications by Akihiro Kawauchi

KOL-Index: 14014 . OBJECTIVES: To examine the clinical utility of the prostate cancer gene 3 (PCA3) urine test in predicting prostate cancer in Japanese men undergoing prostate biopsy. METHOD: The study group included 105 men who underwent extended prostate biopsy based on an elevated serum prostate-specific antigen (PSA). In all cases, the patients' race was Asian. Urine specimens were collected after ...
Known for Prostate Cancer | Pca3 Score | Psa Density | Urine Assay
KOL-Index: 13889 . Dihydropyrimidine dehydrogenase (DPD) is the rate-limiting enzyme in the pathway of uracil and thymine catabolism. DPD is also the principal enzyme involved in the degradation of 5-fluorouracil (5-FU), which is one of the anticancer chemotherapeutic agents currently used in the treatment of bladder cancer. Little is known about the significance of DPD activity in human cancers. We ...
Known for Dihydropyrimidine Dehydrogenase | Dpd Activity | Bladder Cancer | Tumor Carcinoma
KOL-Index: 13484 . PURPOSE: Second mitochondria-derived activator of caspase/direct inhibitor of apoptosis-binding protein with low pI (Smac/DIABLO) was recently identified as a protein that is released from mitochondria in response to apoptotic stimuli and promotes apoptosis by antagonizing inhibitor of apoptosis proteins. Furthermore, Smac/DIABLO plays an important regulatory role in the sensitization of ...
Known for Smac Diablo | Renal Cell Carcinoma | Prognostic Significance | Apoptosis Proteins
KOL-Index: 11614 . PURPOSE: We assessed patient quality of life specific to each of the 7 items on the International Prostate Symptom Score, as evaluated with a novel visual analog scale questionnaire. MATERIALS AND METHODS: A total of 246 male patients with a chief complaint of lower urinary tract symptom were asked to complete the International Prostate Symptom Score and visual analog scale questionnaires ...
Known for Symptom Score | International Prostate | Visual Analog | Quality Life
KOL-Index: 10523 . BACKGROUND: We retrospectively reviewed a large series of Japanese men with histologically proven prostate cancer to assess the clinical characteristics of the cancer in three different eras of prostate cancer management since prostate-specific antigen (PSA) testing started in 1988. METHODS: The medical records of 1125 patients treated between 1975 and 2002 were reviewed with respect to ...
Known for Prostate Cancer | Psa Phase | Specific Antigen | Clinical Characteristics
KOL-Index: 9778 . BACKGROUND: The aim of this study is to ascertain whether Bayer complexed PSA (cPSA) and volume referenced cPSA could enhance the detection of prostate cancer in Japanese men. METHODS: A total of 214 Japanese men whose serum total PSA (tPSA) values ranged from 1.2 ng/ml to 4600 ng/ml were enrolled from two institutions. Serum samples for tPSA, free PSA, PSA-alpha-1-antichymotripsin ...
Known for Prostate Cancer | Tpsa Cpsa | Specific Antigen | Psa Ratio
KOL-Index: 9648 . PURPOSE: We report our initial experience with hand assisted retroperitoneoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma and compared our results to those of a contemporary series of open nephroureterectomy. MATERIALS AND METHODS: Clinical data on 34 consecutive patients who underwent hand assisted retroperitoneoscopic nephroureterectomy were reviewed and ...
Known for Hand Assisted | Laparoscopy Surgery | Transitional Cell | Bladder Recurrence
KOL-Index: 9609 . AIM: Bladder diaries including bladder perception grades were analyzed to assess overactive bladder (OAB) symptoms in community-dwelling women 40 years of age or older. METHODS: Three hundred ten women (mean 58 years) completed a 3-day bladder diary. The perception grades were defined as follows: 0 = no bladder sensation, 1 = sensation of bladder filling without desire to void, 2 = desire ...
Known for Bladder Diary | Urinary Perception | Voided Volume | Normal Urgency
KOL-Index: 9555 . BACKGROUND: For men with clinically localized prostate cancer and candidates to receive radical prostatectomy (RP) a main concern is a cancer recurrence after treatment. Although previous studies have demonstrated the diagnostic utility of diffusion-weighted imaging (DWI) for prostate cancer, the prognostic value of pretreatment DWI has not been investigated yet. PURPOSE: To investigate ...
Known for Prostate Cancer | Biochemical Recurrence | T2wi Dwi | Weighted Mri
KOL-Index: 9353 . PURPOSE: We describe the technical aspects of real-time transrectal ultrasound (TRUS) monitoring and guidance during laparoscopic radical prostatectomy (LRP). Furthermore, we describe the TRUS visualized anatomy of periprostatic structures during LRP. MATERIALS AND METHODS: In 25 consecutive patients undergoing transperitoneal LRP, baseline preoperative, real-time intraoperative and ...
Known for Lrp Trus | Computerassisted Ultrasonography | Laparoscopic Radical | Time Transrectal
KOL-Index: 9227 . The aim of this study is to evaluate the diagnostic performance of transrectal real-time elastography (TRTE) to differentiate benign from malignant prostatic lesions, with pathologic diagnosis obtained by prostatic needle biopsy. Conventional gray scale transrectal ultrasonography (TRUS) and power Doppler ultrasonography (PDUS) were performed in 107 men who had elevated serum ...
Known for Systematic Biopsy | Doppler Ultrasonography | Detection Rate | Time Elastography
KOL-Index: 9029 . In order to evaluate the erectile function in male renal failure patients treated with hemodialysis (HD), we investigated the International Index of Erectile Function (IIEF) in patients and healthy controls. The subjects were 174 male patients treated with HD, of whom 43 had diabetes mellitus (DM) and the remaining 131 patients did not have DM. The controls were 1133 healthy males. We ...
Known for Erectile Function | Renal Failure | Hd Patients | Age Severity

Key People For Prostate Cancer

Top KOLs in the world
#1
Ahmedin M Jemal
united states breast cancer addis ababa
#2
Peter T Scardino
prostate cancer active surveillance erectile function
#3
Rebecca L Siegel
united states colorectal cancer incidence rates
#4
Johnathan I Jonathan
prostate cancer gleason score needle biopsy
#5
Philip W Kantoff
prostate cancer psma adc androgen deprivation therapy
#6
PATRICK CRAIG Walsh
prostate cancer specific antigen pathological stage

Shiga University of Medical Science: Shiga Ika Daigaku | Department of Urology, Shiga University of Medical Science, Shiga, Japan. | Department of Urology, Shiga University of Medical Science, Setatsukinowa-cho, Otsu, Shiga 520-2192, Japan | Departme